EW Stock Edwards Lifesciences Corporation
US · NYSELast in our picks 2026-10-26 — not in the current list; analysis below is from that screen
Structural cardiovascular demand and procedure growth support steady healthcare-device expansion.
Future value: $101.39 (+13.83%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Durable cardiovascular procedure demand supports positive momentum.
- ▸Above 50-day MA (+1.15%)
- ▸Above 200-day MA — long-term uptrend
Is EW a buy right now?
Trend: EW is trading above the 50-day average (+2.86%), RSI 62 — neutral momentum, with a 3-month return of +8.22%.
Valuation & quality: Edwards Lifesciences Corporation trades on a trailing P/E of 53.0, forward P/E 26.8, PEG 1.87, price-to-book 4.92; fundamentals show net margin 15.4%, return on equity 9.2%, revenue growth 13.6% year on year.
Analyst consensus: 27 analysts have a mean 12-month price target of $101.39 (+12% vs the last close; range $84.00 – $110.00), consensus rating “buy”.
Our screen: BUY (score 3) — Structural cardiovascular demand and procedure growth support steady healthcare-device expansion.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -7.40% | +4.30% | +3.60% | +4.60% | -4.90% | +5.40% | -4.90% | +4.90% |
Fundamentals
Analyst price target
Technical signals
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
Sector: Healthcare · Industry: Medical Devices · United States · 16,000 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.